Skip to main content
OpenTrials

Clinical trial condition

HR+/HER2- Locally Advanced, Metastatic Breast Cancer

Explore clinical trials studying HR+/HER2- Locally Advanced, Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HR+/HER2- Locally Advanced, Metastatic Breast Cancer trial results

Recruiting

Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy

NCT06998108

Conditions
Breast Diseases, Breast Neoplasms, HR+/HER2- Locally Advanced, Metastatic Breast Cancer, +4 more
Locations
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
View Trial Details
Completed

UK Ibrance Patient Program (IPP) Study

NCT03921866

Conditions
Breast Diseases, Breast Neoplasms, HR+/HER2- Locally Advanced, Metastatic Breast Cancer, +4 more
Locations
  • Royal Cornwall Hospital Truro, Cornwall, United Kingdom
  • Brighton Sussex Cancer Centre Brighton, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Guys and St Thomas' NHS Trust London, United Kingdom
View Trial Details

Related conditions